About
Celltrion Inc is a South Korean company that was founded in 2002 and specializes in the development and manufacturing of biopharmaceutical products. The company is headquartered in Incheon, South Korea and employs over 2,000 people worldwide.
Annual results
Reported figures, KRW · revenue up 17.0% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 4.2T | 1.0T | 24.7% | — |
| 2024 | 3.6T | 423B | 11.9% | — |
| 2023 | 2.2T | 536B | 24.6% | — |
| 2022 | 2.3T | 538B | 23.5% | — |
| 2021 | 1.9T | 579B | 30.3% | — |
Dividends per share
2026 714.29 KRW2025 654.11 KRW2024 436.07 KRW2023 327.05 KRW2022 628.95 KRW
068270.KS in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Celltrion Inc are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.